InvestorsHub Logo
Followers 74
Posts 2394
Boards Moderated 0
Alias Born 09/07/2014

Re: beartrap12 post# 48745

Thursday, 12/31/2015 10:01:38 AM

Thursday, December 31, 2015 10:01:38 AM

Post# of 711647
If you find the share price unsettling, I suggest you take a look at the numbers I ran for the Ph 3 trial, which are in post 48745, and see if you come up with the same belief I came to....that there is little chance of failing for DCVax L.
Feel free to critique these numbers, change them, see what you get for how well L is working. Can you make L fail without resorting to outrageously long PFS for placebos or ridiculously low enrollment numbers. In the end, the success of DCVax L is important and the only SP number that matters is the one after the FDA speaks. Read between Linda's words: she has said over and over, and repeated it to us at the annual meeting, that regulatory bodies, including FDA, have given NWBO unpresidented leeway in designing their trials to save time. If you guys don't believe in this treatment, well, clearly many people in important places do!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News